Targa Resources Corp. Announces Quarterly Dividend and Timing of Fourth Quarter 2023 Earnings Webcast

Written by Customer Service on January 18, 2024. Posted in Dividend Reports And Estimates.

HOUSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced its quarterly dividend on common shares with respect to the fourth quarter of 2023. Targa announced today that its board of directors has declared a quarterly cash dividend of $0.50 per common share, or $2.00 per common share on an annualized basis, for the fourth quarter of 2023. This cash dividend will be paid February 15, 2024 on all outstanding common shares to holders of record as of the close of business on January 31, 2024. For the first quarter of 2024, Targa intends to recommend to its Board of Directors an increase to its common dividend to $0.75 per common share or $3.00 per common share annualized. The recommended common dividend per share increase, if approved, would be effective...

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Written by Customer Service on January 18, 2024. Posted in Mergers And Acquisitions.

SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah where the Precise Tumor Test is currently performed. The acquisition is expected to close on February 1, 2024, subject to customary closing conditions. By bringing the Precise Tumor and Precise Liquid tests in house, Myriad will open up new opportunities for innovation, growth, and continued development of its oncology portfolio. “With this acquisition, we’re deepening our commitment to our oncology business while also generating...

Hubbell to Announce Fourth Quarter 2023 Results on January 30, 2024

Written by Customer Service on January 18, 2024. Posted in Public Companies.

Shelton, CT, Jan. 18, 2024 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) today announced it will release its fourth quarter 2023 financial results prior to the opening of the market on January 30, 2024. The Company will then webcast its Analysts’ Conference Call to discuss the results at 10:00 AM ET. The full text of the press release announcing the results will be posted on Hubbell’s corporate website under the Press Release section. You can also access this information by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Press Releases” from the drop-down menu. The live audio of the conference call and accompanying materials will also be available and can be accessed by visiting Hubbell’s Events and Presentations section. You...

Irish Residential Properties Sub-Fund 1: Form 8.3 – Irish Residential Properties REIT PLC

Written by Customer Service on January 18, 2024. Posted in Mergers And Acquisitions.

Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) — FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Irish Residential Properties Sub-Fund 1 (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Irish Residential Properties REIT Plc (d) If an exempt fund manager connected with an offeror/offeree, state...

PREMIER DIVERSIFIED HOLDINGS INC. Reports on Delay in Filing of Annual Filings

Written by Customer Service on January 18, 2024. Posted in Public Companies.

Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) — Premier Diversified Holdings Inc. (“PDH” or the “Company”) (TSXV: PDH) is announcing that it has completed the filing of an application seeking a management cease trade order (the “MCTO”) under National Policy 12-203, from the British Columbia Securities Commission (“BCSC”). The Company has filed an application seeking an order for a MCTO from the BCSC because the Company may be unable to file its annual financial statements for the year ending September 30, 2023, including the related management’s discussion and analysis and certifications from the CEO...

Toll Brothers Opens Two Model Homes at The Ridge at Big Rock Community in Duvall, Washington

Written by Customer Service on January 18, 2024. Posted in Public Companies.

The Ridge at Big Rock by Toll Brothers Toll Brothers announced the grand opening of two new model homes at its luxury home community in Duvall, Washington, The Ridge at Big Rock. The Ridge at Big Rock by Toll Brothers The Ridge at Big Rock by Toll Brothers, a new pedestrian-friendly resort-style community, opens two brand new model homes in Duvall, Washington. DUVALL, Wash., Jan. 18, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced the highly anticipated opening of two brand new model homes at The Ridge at Big Rock, a new pedestrian-friendly community located only 12 miles from downtown Redmond in Duvall, Washington. The public is invited to attend a grand opening event to be held at the community this Saturday, January 20 from noon to 4pm PT. The professionally...

Nexus Industrial REIT Announces January and February Distributions

Written by Customer Service on January 18, 2024. Posted in Dividend Reports And Estimates.

TORONTO, Jan. 18, 2024 (GLOBE NEWSWIRE) — Nexus Industrial REIT (“Nexus” or the “REIT”) (TSX: NXR.UN) announced today the declaration of the January and February 2024 distributions. The REIT will make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized basis, payable February 15, 2024 to unitholders of record as of January 31, 2024. The REIT will also make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized basis, payable March 15, 2024 to unitholders of record as of February 29, 2024. The REIT’s distribution reinvestment plan (“DRIP”) entitles eligible unitholders to elect to receive all, or a portion of the cash distributions of the REIT reinvested in units of the REIT. Eligible unitholders who so elect will receive a...

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

Written by Customer Service on January 18, 2024. Posted in Public Companies.

DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it recently received a communication from the European Patent Office (EPO) that it has been granted a patent with claims directed to mebufotenin (5-MeO-DMT) or a pharmaceutically acceptable salt thereof for use in treating patients diagnosed with major depressive disorder (MDD) and treatment-resistant forms of MDD, such as treatment-resistant depression (TRD). The newly granted patent, EP3927337, which will have an effective date of February 14, 2024, and an expiry date of no earlier than 2040, is expected to cover all mebufotenin (5-MeO-DMT) and mebufotenin salt products for use in the treatment of MDD...

Kane Biotech Announces Special Meeting of Shareholders

Written by Customer Service on January 18, 2024. Posted in Public Companies.

WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on February 20, 2024, the Company will hold a special meeting of its shareholders (the “Meeting”) to consider the election of Dr. Robert Huizinga as an additional director of the Company. The information circular and other materials with respect to the Meeting will be filed on SEDAR+ by the Company in due course. Dr. Huizinga is currently the principal of Reformation Consulting Services. He was formerly the Executive Vice-President of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) and led the clinical development of voclosporin which had first year sales of $100 million USD. Prior to that, Dr. Huizinga was the Vice President of Clinical Affairs for Isotechnika Inc, and was a clinical...

Lincoln Electric Schedules Webcast for Fourth Quarter and Full Year 2023 Results

Written by Customer Service on January 18, 2024. Posted in Public Companies.

CLEVELAND, Jan. 18, 2024 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its fourth quarter and full year 2023 results on Thursday, February 15, 2024 prior to market open. An investor conference call and webcast will take place at 10:00 a.m. (ET) later that day. The event is available via webcast in listen-only mode and can be accessed here or on the Company’s Investor Relations home page at https://ir.lincolnelectric.com. To participate via telephone, please dial (888) 440-4368 (domestic) or (646) 960-0856 (international) and use confirmation code 6709091. Telephone participants are asked to connect 10 minutes prior to the start of the conference call. A replay of the earnings call will be available via webcast on the Company’s website. About Lincoln...

Day: January 18, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice